A double-blind trial was conducted which attempted tot comprre and wrutraet the therapeutic effects of haloperidol and thiorieazine i n1 a chronic schizophrenic population. The psychiatric use of these two druylis, one a butyraphenme, the other a phenothiazine, is discussed with reference to the management of this clinical population.